Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pia Boström

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cancers|January 8, 2025
Low-Grade Adenosquamous Carcinoma of the Breast: A Single-Center Retrospective Study and a Systematic Literature ReviewAnselm Tamminen, Pia Boström
Oncology|March 10, 2021
Are Breast Cancer Nomograms Still Valid to Predict the Need for Axillary Dissection?Vilma Madekivi, Antti Karlsson, Pia Boström, et al.
Anticancer Research|July 3, 2017
The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary DissectionVilma Madekivi, Pia Boström, Ritta Aaltonen, et al.
Histochemistry and Cell Biology|September 26, 2012
Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breastPia Boström, Annele Sainio, Tanja Kakko, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|June 28, 2017
Human Metaplastic Breast Carcinoma and DecorinPia Boström, Annele Sainio, Natalja Eigėlienė, et al.
BMC Research Notes|July 21, 2009
Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factorsPia Boström, Mirva Söderström, Tuire Palokangas, et al.
BMC Cancer|August 13, 2011
MMP-1 expression has an independent prognostic value in breast cancerPia Boström, Mirva Söderström, Tero Vahlberg, et al.
BMC Medical Imaging|December 30, 2017
MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility studyKirsi Holli-Helenius, Annukka Salminen, Irina Rinta-Kiikka, et al.
Plos One|October 23, 2013
Lack of decorin expression by human bladder cancer cells offers new tools in the therapy of urothelial malignanciesAnnele Sainio, Marie Nyman, Riikka Lund, et al.
Journal for Immunotherapy of Cancer|May 16, 2025
Macrophage sensitivity to bexmarilimab-induced reprogramming is shaped by the tumor microenvironmentJenna H Rannikko, Rita Turpin, Pia Boström, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancers|January 8, 2025
Low-Grade Adenosquamous Carcinoma of the Breast: A Single-Center Retrospective Study and a Systematic Literature ReviewAnselm Tamminen, Pia Boström
Oncology|March 10, 2021
Are Breast Cancer Nomograms Still Valid to Predict the Need for Axillary Dissection?Vilma Madekivi, Antti Karlsson, Pia Boström, et al.
Anticancer Research|July 3, 2017
The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary DissectionVilma Madekivi, Pia Boström, Ritta Aaltonen, et al.
Histochemistry and Cell Biology|September 26, 2012
Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breastPia Boström, Annele Sainio, Tanja Kakko, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|June 28, 2017
Human Metaplastic Breast Carcinoma and DecorinPia Boström, Annele Sainio, Natalja Eigėlienė, et al.
BMC Research Notes|July 21, 2009
Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factorsPia Boström, Mirva Söderström, Tuire Palokangas, et al.
BMC Cancer|August 13, 2011
MMP-1 expression has an independent prognostic value in breast cancerPia Boström, Mirva Söderström, Tero Vahlberg, et al.
BMC Medical Imaging|December 30, 2017
MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility studyKirsi Holli-Helenius, Annukka Salminen, Irina Rinta-Kiikka, et al.
Plos One|October 23, 2013
Lack of decorin expression by human bladder cancer cells offers new tools in the therapy of urothelial malignanciesAnnele Sainio, Marie Nyman, Riikka Lund, et al.
Journal for Immunotherapy of Cancer|May 16, 2025
Macrophage sensitivity to bexmarilimab-induced reprogramming is shaped by the tumor microenvironmentJenna H Rannikko, Rita Turpin, Pia Boström, et al.
Pageof 3